Scientific User Meeting 2017

13.09.2017 | Scientific User Meeting 2017

Get updated on the most recent research in special protein analysis and meet Nordic colleagues from the field.

 
One-day scientific seminar on Wednesday, November 15, 2017, in Copenhagen, Denmark. 

Among the subjects are:
  • Multiple Myeloma
  • Multiple Sclerosis
  • Optilite® - a solution for your protein lab

 

Who is the user meeting for?

The user meeting is for everyone interested in myeloma and/or special proteins.

What is the cost?
Participation is free of charge. However, there is a no-show fee of €100, if you do not show up without informing us.

When should I sign up?
Please sign up by Wednesday, October 11, 2017.

Where does the seminar take place?
Hotel Quality Airport Dan, Kastruplundgade 15, DK-2770 Kastrup

Transport from Copenhagen Airport
15 min by foot, take the shuttle service from Terminal 2 or take the metro M2 to Kastrup station.
Transport from Copenhagen Central Station
Bus 5C (towards Copenhagen Airport) to Kastruplundgade.

 

 

Program 

Wednesday, November 15, 2017

 

9:45 Welcome

10:00 Introduction to Optilite®
- Steve Smith, International Marketing Manager, The Binding Site

10:45 Clinical utility of Freelite® and Hevylite® assays – Part 1: Diagnosis
- James Last, Medical Science Liaison Manager, The Binding Site

Multiple Myeloma:
  • IMWG MM diagnostic criteria
  • Optimal assay panel for MM investigation
  • IMWG and NICE recommended screening algorithms

Multiple Sclerosis:

  • CSF Kappa FLC index for MS diagnosis
  • CSF Kappa FLC index for CIS prognosis


11:25 Coffee break

11:35 Clinical utility of Freelite® and Hevylite® assays – Part 2: Monitoring MM patients
- James Last, Medical Science Liaison Manager, The Binding Site

LCMM patients:

  • Serum Freelite® vs urine BJP for response assessment

IIMM patients:

  • Freelite® monitoring of IIMM to detect light chain escape
  • Freelite® monitoring of IIMM to help define a stringent complete response
  • Freelite® to monitor response to monoclonal antibody therapies
  • Hevylite® to monitor IgA MM
  • Hevylite® can further stratify patients achieving VGPR by IMWG response criteria
  • Hevylite® for the detection of residual disease
  • Freelite® and Hevylite® as gateway tests to MRD


12:15 Lunch
- Optilite demos available upon request.

13:15 Introduction to Vaccine Response and IgG subclasses
- Mark Perkins, International Product Manager – Assays, The Binding Site

13:45 TBSG Assays in Development
- Mark Perkins, International Product Manager – Assays, The Binding Site

14:00 User presentations
- *Presenters to be announced*

14:45 Coffee break

15:00 User discussion and feedback session


16:00 End of program
 

 

If you have any questions, please do not hesitate to contact: 

Pauline Rüdiger, Nordic Application Manager, Clinical Biochemistry and ELISA • par@ahdiagnostics.dk • +45 87 45 90 13

 

Search webshop

Enter catalog number, product name, supplier
or a combination


 
 

SUPPLIERS

See all suppliers